Financials

  • Market Capitalization 322.15 M
  • Employee 116
  • Founded 2013
  • CEO Shankar Musunuri
  • Website www.ocugen.com
  • Headquarter Delaware, United States
  • FIGI BBG00194VJB1
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-5.87
Relación precio/flujo de caja
91.83

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
3152
TTRX
Turn Therapeutics Inc. - Common Stock
11.11 USD-7.42%-10.04%-10.62%+79.19%330.95 M USD
3172
INDP
Indaptus Therapeutics, Inc. - Common Stock
2.44 USD-2.79%-2.79%-12.86%+28.42%325.11 M USD
3198
BNTC
Benitec Biopharma Inc. - Common Stock
9.07 USD+2.25%-2.68%-25.90%-45.39%316.39 M USD
3219
AGMB
AgomAb Therapeutics NV - ADRs representing one
9.09 USD+0.11%+3.65%-31.14%-38.16%310.58 M USD

Noticias